Healthcare Startups funded by Y Combinator (YC) 2024

Ginkgo Bioworks is the organism company. We design custom organisms for customers across multiple markets. We build our foundries to scale the process of organism engineering using software and hardware automation. Organism engineers at Ginkgo learn from nature to develop new organisms that replace technology with biology.

Notable Labs is building a personalized drug discovery platform to identify treatment options for relapsed and refractory cancer patients — starting with blood cancer — to address the long tail of cancer treatment. We look at a person’s actual cancer cells, test combinations of FDA approved drugs, and see which combinations kill the cancer cells and leave the healthy cells alive. We focus on combinations because cancer is often difficult to target with just one drug and starting with a single drug can lead to resistant clones or relapse. We're building a highly automated lab in Foster City running on our custom software and are currently testing relapsed/refractory cancer patients as well as samples from a variety of pharma/biotech partnerships. https://www.notablelabs.com/careers

We make oral drugs to treat and prevent viral infections - like COVID-19.

Diassess Inc. is revolutionizing the way infectious diseases are prevented, diagnosed, and monitored by developing the tools necessary to empower people to become knowledgeable about their health. We produce inexpensive, disposable health diagnostic hardware that transforms any smartphone into a portable, real-time health-monitoring device for rapid, accessible, multiplexed analysis of bodily fluids anywhere in the world.

Clipboard Health exists to lift as many people up the socioeconomic ladder as possible. We dramatically improve lives by letting healthcare professionals turn extra time and ambition into career growth and financial opportunity. We achieve this with our app-based marketplace that connects healthcare facilities and healthcare professionals, allowing healthcare professionals to book on-demand shifts and healthcare facilities to access on-demand talent. Our mission is to enable healthcare professionals to work when and where they want and to enable healthcare facilities to meet their talent needs. Clipboard Health is a fast-growing Series C startup with classic two-sided network effects. We have product-market fit, generate substantial revenue, and we are helping nurses fix healthcare one shift at a time. Clipboard Health is a diverse and inclusive company with a global, remote-first team of hundreds of people. We’ve been featured on YC’s Top Companies and grown our revenue 25x in the last 18 months. We need your help to keep growing so we can serve more healthcare professionals, healthcare facilities, and patients.

Nurx is a telemedicine startup focused on increasing access to healthcare, starting with birth control and PrEP services.

We're a women’s health company making personalized reproductive health information more accessible, earlier in life. We make the same laboratory tests that were previously confined to fertility clinics more accessible for women at home. By arming women with powerful information about their reproductive health, Modern Fertility is closing the fertility information gap and enabling women to own the decisions impacting their bodies and futures. We've raised $22 million from Forerunner Ventures, Maveron, Union Square Ventures, First Round Capital, #Angels and Y Combinator.

DrChrono develops the essential platform and services for modern medical practices to make care more informed, more interactive, and more personalized. The open platform powers telehealth, electronic health record (EHR), practice management, medical billing, and revenue cycle solutions for physicians and patients, and is fully extensible via a robust API and marketplace of applications and services. The platform is used by thousands of physicians and millions of patients, and is facilitating millions of patient appointments and is processing billions of dollars in medical billing. For more information about DrChrono, visit www.drchrono.com

Helium Health provides a suite of digital health tools for healthcare providers, payers and patients across Africa — most prominent of which is our maiden electronic medical records (EMR) & hospital management information system (HMIS) for emerging markets, HeliumOS. We offer business loans to healthcare providers through our HeliumCredit product. We also work with donors and governments in executing public health strategies. Finally, we have built the largest healthcare data repository on Africans with over 1 million health records.

Bodyport’s cardiovascular sensing weight scale and predictive algorithms detect early changes in cardiac function to help prevent avoidable hospitalizations. Bodyport is initially targeting heart failure, a chronic condition affecting over 6M Americans and a leading cause of hospitalizations (1M/year) and healthcare spending ($35B/year). Bodyport’s novel scale measures cardiac output, congestion, heart rate, and other leading indicators of cardiovascular health — all in the same step patients already take to weigh themselves. Companion algorithms and software empower care teams to quickly identify at-risk patients and remotely optimize their therapy to prevent deterioration.

Every hospital hires clinical pharmacists to answer clinical questions from doctors. They outsource this to us because we’re more efficient.

BIOS Health was previously called Cambridge Bio-Augmentation Systems (CBAS) and focused on prosthetic neural interfaces as a first market. Now we use

Today's funders are so conservative they only fund the most obvious ideas. At Experiment, we fund the ideas that they won't fund; the ideas that matter. Since founding, over 47,000 citizens have pledged $9 million dollars supporting 900 scientific projects on the platform. 46% of all projects on Experiment are successfully funded. When the projects are finished, the scientists share the scientific results with their backers as lab notes and peer-reviewed publications. Scientists from Stanford, Harvard, and Yale have chosen to use Experiment instead of writing grants. Bill Gates recognized Experiment by saying "this solution helps close the gap for potentially-promising but unfunded projects."

HistoWiz is an innovative company dedicated to accelerating pathology-based research. HistoWiz provides fast, global access to digital whole-slide images, online collaboration tools, low-cost data management, and experimental pathology expertise. The web-based platform accelerates information exchange among medical scientists and research pathologists. HistoWiz's mission is to fight cancer cooperatively instead of individually by connecting scientists and pathologists for online collaboration. The HistoWiz advantage We help your lab minimize the cost of research and maximize research productivity by providing the most efficient service for scientists to analyze experimental pathology specimens. We believe that scientists should spend their time on results interpretation rather than repetitive tissue cutting. How does it work? HistoWiz accepts formalin-fixed specimens by mail for tissue processing services. To expedite delivery of results and to facilitate global collaboration, HistoWiz offers whole-slide imaging and pathology services, allowing researchers to remotely and instantly view high-magnification images of their specimens via a secure, cloud-based “virtual microscope” on any computer or mobile device without downloading any software or gigabyte-sized files.

Developing AI tools and LLM for Healthcare

Kairo Health builds AI agents that help deliver patient care at a fraction of the cost. The US has a shortage of nurses, care coordinators, and administrators, all of whom spend a significant portion of their days navigating disparate software systems like their EHR and waiting on hold for hours over the phone. Organizations have little incentive to grow these teams, which leads to burnout and inefficiency. Kairo scales this support staff by recording their actions and translating them into instructions for our agents to execute on their own. Organizations can deploy these agents for any care delivery workflow, such as calling patients to check-in on their symptoms, rescheduling a clinician’s panel in case of an emergency, and filling late cancellation slots with other patients.

Burdensome documentation is the #2 reason causing burnout for physical therapists. More than half of all physical therapists have to write documentation in their free time without pay. up to 2 hours a day. Our AI Scribe listens, generate first draft of clinical documentation in minutes, and sync reviewed documentation to EMR in 2 seconds. With us, clinicians can finish documentation 70% faster and become happier.

Nectome is a neuroscience startup that aims to preserve the brain and keep all its memories intact. The company is building the next generation of tools to preserve the connectome. The connectome is all the connections called synapses between neurons in the brain. Researchers from the company is now learning to manipulate individual memories, building advanced brain prosthetics, and reverse-engineering the brain.

Syrona is a solution tackling diversity and Inclusion, for 45% of the workforce that go through women's health events from Endometriosis through to Menopause. We do this though our virtual clinic which provides personalised diagnostic, telemedicine and evidence based self-management tools. The areas we cover are Endometriosis, PCOS, Fertility, Parenthood, Cancer or Menopause.

Humane Genomics has developed a platform to engineer cancer killing viruses. We have taken a first principles approach to design and make oncolytic viral therapies. Using a highly lytic RNA virus engineered with "2 factor authentication" (using selective infection and selective replication) they have an on-target to off-target kill ratio > 1000. We are working on our first indication, pediatric liver cancer (hepatoblastoma), with our partners at Texas Children's Hospital, who are world leading experts. We have in vivo (mouse) data showing safety and currently developing efficacy data and are showing 50% reduction in tumor volume.

Eugit Therapeutics targets the issue of non-specific drugs that cause toxicity and clinical trial failures, affecting millions with tissue-specific inflammatory diseases. TAGHOME delivers drugs with precision to diseased tissues using T cell receptors, enhancing safety and improving efficacy. Our initial focus is on the 3.1 million U.S. individuals with Inflammatory Bowel Disease, aiming to initiate clinical trials within two years. Cofounded by George Church (Harvard) and funded by Y Combinator (S22).

We have developed an AI platform enabling to accelerate the discovery and the design of genomic therapies such as Cell Therapies, RNA Therapies and DNA Therapies.

Kernal Bio creates mRNA 2.0 therapies that instruct specific cells on how to make their own medicine. Kernal Bio encrypts mRNA’s “message” in a language that only cancer cells understand. These tumor-specific mRNA therapeutics allow precise targeting of cancer cells, without harming normal cells or tissues. They have recently been validated in preclinical tumor models, showing high efficacy and safety as well as durable adaptive immunity. With roots at MIT, Harvard and Biopharma, Kernal’s management team has deep expertise in mRNA therapeutics space. CEO Yusuf Erkul, M.D., M.B.A. is a successful drug hunter whose research at Merck enabled an FDA-approved drug for ovarian cancer. President, Burak Yilmaz, M.S., previously founded Sentegen, a thriving synthetic biology company which commercializes synthetic DNA, RNA, and diagnostic kits for genetic and infectious diseases. VP of BD, Matt Strout, M.D. Ph.D., M.B.A, is a business development executive who led more than $4.5B worth of BD deals at Alexion and AstraZeneca. VP of R&D Manfred is a leader in immuno-oncology, who was most recently Scientific Senior Director at Bristol-Myers Squibb (BMS).

Culture Biosciences grows cells for biotech companies. Our customers genetically modify organisms to produce new therapeutics, materials, fuels and foods. We help them quickly run experiments and develop manufacturing processes so they can get their products to market faster. We've built proprietary software and automation systems to make operating our bioreactors more efficient than existing systems. We also provide customers with new software tools that help them analyze and contextualize their data. We are currently serving a number of biotech customers and scaling out our infrastructure.

There are 10 million dialysis and bypass surgeries per year, but half of them fail. VenoStent saves lives with a wrap that goes around blood vessels during surgery so they don't fail.

If we've learned anything in the last few years it's that spending time with our friends and family is essential to our well-being and happiness. Unfortunately, loud and noisy places like weddings and family gatherings hinder human connection, especially for the hearing impaired. In fact, the biggest unmet need in the entire hearing healthcare industry is hearing in noisy places. AudioFocus helps patients hear in these environments by only enhancing voices nearby the patients and ignoring ones farther away. We do this using acoustics informed machine learning and custom microphone array design. Our goal is to increase the adoption rate of 37M US adults with hearing loss, only 8M use hearing aids today. Founded by Auditory Neuroscientist & AI expert and a Hearing Aid hardware design expert.

Soma Lab creates simulated conversations with AI patients to scale healthcare training. Students and providers practice with AI patients to build skills and get evaluated.

Chorrie is a no-code platform that puts AI in the hands of medical billing teams to prevent denied and under-billed insurance claims. We use LLMs to empower billing teams to turn their manual claim QA into automated correctness checks. Co-founders Chris and Jorrie are MIT computer science grads and went on to work at Google, where they used similar applied AI techniques to automate content moderation workflows and prevent real-world threats. Within a month of launching with our first client, an ophthalmology practice with 8 clinics and 4 surgery centers, Chorrie has already flagged over $300k of claims that were either under-billed, or would've been denied. Learn more at www.chorrie.com.

HealthSpark empowers physical therapists to launch and run an AI-native independent practice by automating admin tasks like insurance, scheduling, handling calls and texts, and charting.

At Brighterway, we use AI to speed up the medical record review process for physicians in medlegal exams. Physicians spend hours reviewing thousands of pages of medical documents– our technology highlights the information that is most relevant to a doctor's specialty, streamlining their review process and saving them time. Brighterway structures and deduplicates disorganized medical records (PDFs) and extracts the content that is medically relevant and related to a doctor's specialty, so they can focus on what matters most.

Solugen is decarbonizing the chemistry of everyday life with enzymes and innovative metal catalysts. Our new to the world Bioforge platform technology can produce high value chemical goods that are biobased and carbon negative, at cost on par with current technologies. We are making sustainable chemistry accessible to all living things, to ensure a prosperous world exists for generations.

The future of mRNA therapeutics is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible enables the next generation of mRNA medicines by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA in a scalable and cost-effective way.

We are a service for people to learn about their personal environmental exposures. Our first product is a urine test for exposure to chemicals in everyday products.

Stealth-mode, rapidly scaling, venture-backed startup at the vanguard of automated robotic surgery revolution -- just closed our Series A round. We are improving access to dental care in underserved populations by combining novel imaging technology with AI and surgical robotics to automate surgery in the $452B dental industry. We are bringing a new imaging modality to dentistry which can see inside teeth and below the gingiva all without the need for x-rays. AI is used to diagnose decay and plan treatment. Automated robotics reduces the time for surgery down to one minute, reducing patient discomfort and saving time and reducing cost for the dentist. YC 2020, Winner of the Forsyth DenTech 2021 CareCaptial award

Rev Genomics is a plant biotechnology company that provides breeders, growers, and retailers with novel cultivars to differentiate themselves in high value markets.

MediSearch gives direct answers to medical questions based on trustworthy sources.

TYBR is developing a hydrogel to limit internal scarring after surgery. The naturally derived material is applied to coat tendons at the end of surgery to improve healing outcomes for the millions Americans who undergo tendon or ligament surgery each year.

At Verse Therapy, we're dedicated to making quality speech therapy accessible for everyone by empowering speech-language pathologists (SLPs) to launch and grow their own independent practices. We help therapists focus on what they do best—providing compassionate, personalized care—by taking care of the administrative tasks that often lead to burnout. Through thoughtful marketing and partnerships with care organizations like rehab centers, we connect SLPs with individuals who need their expertise. Our AI-enabled back office streamlines insurance processing, scheduling, and documentation, reducing non-therapy overhead. We're now live in 10 states with over 35 dedicated therapists and are in-network with leading insurance providers, making it easier for clients to receive the support they need.

Invitris radically simplifies how we create novel biological drugs. Our patent-pending technology platform turns DNA into synthetic proteins and was recently featured in the Science magazine. It makes creating new drugs >10,000x more efficient at <100x lower costs of material. Our killer application is enabling the newest generation of synthetic bacteriophages to combat antibiotic-resistant infections, which are threatening to cause more deaths than all cancers combined.

Cancer is a genetic disease. We know this from decades of human and veterinary cancer research. Precision medicine and targeted therapies are successfully used to treat humans with cancer. At FidoCure®, we bring this approach to the world of veterinary medicine. FidoCure® empowers veterinarians to offer genetic sequencing and targeted therapies to treat dogs with cancer. We are committed to expanding the veterinary oncology toolbox for both diagnostics and therapeutics. Our veterinary partners have treated thousands of dogs over the past 30 years and work closely with the growing FidoCure® network of over 143 clinics and 180 forward-thinking veterinary oncologists throughout the US. Together, we can combat canine cancer!

MentalHappy is a secure and compliant platform that leverages AI and data-driven analytics to enhance the group-based therapy experience and boost client/patient engagement. Our platform streamlines administrative tasks for providers, improves group participant self-management capabilities, automates group participant check-ins, and identifies group members who may be at risk. Additional features on the platform allow providers to schedule and host virtual sessions, engage members in secure chat, and share health resources, and offer support groups

CareMessage is the technology non-profit building the largest patient engagement platform for low-income populations in the United States. Powered by the Health Equity Engine™, the platform enables organizations to combine messaging, data, and interoperability to increase access to care, improve clinical outcomes, and address social drivers of health. With 20 million patients reached since 2013, CareMessage is the only patient engagement solution proven to improve health equity at scale. The team, many with lived experiences in these communities, leverages a nonprofit model to reinvest revenue into impact. CareMessage is the partner of choice for organizations committed to advancing health equity.

We're building autonomous robots to make surgery safe, easier and more efficient. Robots currently perform about 1/4 of surgeries but only help with the physical aspects. We use AI to make surgery cognitively easier. This has far greater potential to improve outcomes and reduce costs. Founded by 3x founders from medtech and autonomous vehicles, we're on track to be the fastest surgical robot to market of all time. First indication is prostate enucleation.

Engage Bio is developing mRNA immunotherapies to defeat cancer. Our founders have deep experience in immunotherapy development, including four drugs in the clinic, and in building mRNA therapeutics platforms. Our approach is to provide cancer cells with instructions to make and gradually release our drugs within solid tumors. This local therapy allows us to eliminate tumors while sparing healthy distant tissues.

Dear Brightly offers prescription skin products online. Our mission is to get people access to the most effective, dermatologist vetted skincare products for healthy skin, using technology.

For the first time in history, technology exists to create a healthcare system that anticipates your needs and responds with precision, and is always accessible to all, regardless of financial means or geography. Since 2015, Akido Labs singular focus has been to make this vision a reality.

Iona Mind is building the first fully-digital care pathway for common mental health issues. Our products are based on Cognitive Behavioural Therapy (CBT), one of the most effective evidence-based forms of treatment, which is delivered in a fully automated way using a conversational interface. Unlike other wellbeing apps, our exercises and programs are evidence-based, with over 300 peer reviewed journal papers showing the efficacy of CBT in the treatment of many common mental health conditions.

Medication errors cost the healthcare industry $40 billion each year, the largest contributor being the manual processes employed by pharmacies. Wattson Health's automation platform integrates with pharmacies' existing systems and enables them to fill prescriptions error-free in a matter of seconds vs. hours or even days.

Full Sleep by Koko Labs is the first at-home sleep program that combines the power of clinical grade, radar based wireless sleep tracking with best-in-class CBT-I sleep techniques. Full Sleep delivers daily lessons developed with evidence-based principles. The multi-week curriculum is customized based on your daily overnight sleep data and other health conditions that could impact sleep, such as menopause, chronic pain, or depression. Learn how to challenge assumptions, change habits, and introduce behaviors to help you fall and stay asleep.

Starling is building a urine diagnostic remote patient monitoring platform that seamlessly integrates into anyone's bathroom routine. By detecting early changes in a patient's urine using our toilet indwelling mass spectroscopy device, our platform is aiming to prevent hospitalizations from numerous conditions like recurrent UTIs, BPH exacerbations, or diabetes. We do this while creating significant new annual revenues for our clinician partners from remote patient monitoring reimbursements without requiring any significant changes in a staff's day to day schedule.

Rosebud Biosciences accelerates drug development by screening drugs against organoids (micro-organs) that have the same gene mutations as the patients. We partner with therapeutics companies to screen their drugs, and we perform our own drug discovery for rare diseases that have no existing treatments. Our organoids are also fetal-like and enable discovery of novel drug targets for pediatric diseases. This technology was validated at Stanford, published in a prestigious journal, and has already led to the discovery of a drug target in a pediatric heart disease that could not have been found using traditional disease models.

Rinse is building the One Medical for dental. Beautiful studios, easy to book same day appointments, and anxiety-free care focused on prevention, not the upsell.

X-ZELL™ is a global start-up specialising in rare cell detection technology. Backed by Y Combinator and various high-profile angel investors from around the globe – among them Gmail creator Paul Buchheit – X-ZELL™ has developed a world-first platform technology capable of isolating and visualizing rare and abnormal cells such as Circulating Endothelial Cells (CEC). X-ZELL™’s platform technology is based on four core modules covering the entire spectrum from blood processing through to cell analysis and reporting – with every step performed in-house using patented and proprietary technology. By combining the wisdom of 4,000 years of pathologic research with X-ZELL™’s own, cutting-edge technology, X-ZELL™ ensures robust results and maximum clinical utility across a broad range of medical applications – from research through to medication management, companions diagnostics, relapse control and diagnostic decision-making. More information on www.x-zell.com and @XZELLInc

Current Description: RTHM provides virtual-first care for complex illness including Long COVID, ME/CFS, POTS, and mast cell activation. Many clinics focus on teaching patients how to better cope with symptoms, which is helpful, but we don’t stop there. We develop collaborations & partnerships so our patients access to the most promising testing and root-cause directed early therapies for their illness(es) with the goal of simplifying and streamlining the most efficient and effective clinical pathways so they can be scaled in the form of low cost online modules overseen remotely by clinicians. In conjunction with clinical care, RTHM operates a clinical lab and collects deep molecular data with robust clinical context to develop AI-powered diagnostics and better ways of predicting which treatments may work best for whom.

We're building curative gene therapies for kidney diseases. Our initial focus is on polycystic kidney disease (PKD), which affects 600,000 Americans and has no effective treatment or cure.

Genomelink is a DNA App Store. If you got DNA tested from companies like 23andMe/Ancestry, you can transfer your DNA data to Genomelink and unlock hundreds of unique apps like: 🧬Global ancestry report that goes deeper than 23andMe. 🧬More varieties of body and mind traits analysis than that are available on Ancestry. Team: Tomo from M3, Inc. ($70B medical platform), Yuta from MyCode (#1 consumer genetic testing in Japan), Ken from Sony (tech & bio-info lead at a joint venture between Illumina and Sony), and Carlos Bustamante, P.I. from Stanford University. The investor and affiliates include Y Combinator (S21), Sompo (Top insurance CVC in Japan, led deals for Palantir and Noom), Sony, Berkeley SkyDeck, and StartX.

Obento Health is redefining the CRM experience for medical field sales. Designed specifically for healthcare, we are saving reps time from documentation and empowering reps to create more personalized interactions with their customers.

We're a SaaS company with emphasis on Service, and we have a mission: to improve the happiness of scientists and the quality of their research. HappiLabs provides a service called the Virtual Lab Manager. We offer PhD level, former scientists to help with safety and regulatory, product research, lab shopping, negotiating, purchasing, inventory, and bookkeeping. Our software tools, such as the ETA Dashboard and the HappiApp, make it easy to request purchases, manage inventory, and check-in packages upon delivery. HappiLabs also has one of the most extensive databases of product prices. These tools, and experienced humans, make us the smartest lab managers in the world. Another way to think of us is an outsourced purchasing department and/or a personal assistant for your scientists. Based in Chicago, and some presence in San Francisco. If you're a newly funded PI, a startup, small biotech, or work with purchasing as a big pharma/biotech, you can use our help.

Shasqi is leading the development of therapeutics leveraging click chemistry to get active cancer treatments to tumors with its proprietary CAPAC™ platform. Our technology is based on localizing a click chemistry reagent in the tumor area, which then activates a second agent, a systemically infused protodrug. When the two 'click', a powerful localized therapy is activated at the tumor, while keeping its systemic exposure levels below toxic thresholds.

Makani Science is a medical device company based in Irvine, California. We have created the world's first wireless patch that can accurately and continuously monitor breathing. The company is co-founded by Dr. Michelle Khine and Dr. Michael Chu, two experts in the wearable monitoring space from the University of California, Irvine. The Makani Science system will collect unique breathing waveforms from patients in everyday environments to create the first large database of respiratory patterns associated with different diseases. Data will be collected through systems sold to our initial beachhead market, where we will help improve monitoring safety in patients being sedated for medical procedures. Our long-term goal is to combine machine learning with this database to identify and predict respiratory complications for different patient populations. We have a highly experienced team and will be FDA cleared in our beachhead market within a year.

Menten AI designs protein drugs and enzymes using quantum computing and machine learning. Their technology leapfrogs current computational methods making it possible to design previously intractable proteins. The team created the first protein design algorithm for current and near-term quantum computers and created the world’s first protein designed on a quantum computer. They are now working on 3 new proteins, including a peptide to prevent the spread of viruses like Covid-19. They have 2 paid pilot projects with multinational chemical companies and 4 LOI’s with pharma and biotech companies.

Breathe Well-being helps people prevent or manage chronic lifestyle diseases by losing weight through its digital therapeutics program (weight-loss clinic in a cloud, think Noom for India). The program is delivered remotely over the phone and through the mobile app, therefore users are able to follow the lifestyle program from the convenience of their home. Our online program is 3X more effective at 1/4th the cost. The user receives bi-weekly 1-1 coaching focused on behavioral changes, online community for support and motivation, and a mobile app that provides educational lessons, lifestyle tracking tools and weekly challenges (gamification). The content and behavioral change techniques are centred around healthy diet, fitness, lifestyle and stress reduction. Our unique coaching methodology employs cognitive behavioral therapy (CBT), goal-oriented treatment and self-efficacy enhancement. The coach helps the user bust negative emotions of past failures in weight-loss and increase motivation by linking short-term achievable goals with the user's personal values. Through the program, the user is able to self-identify triggers of unhealthy habit adoption and make better decisions. Breathe Well-being has demonstrated success in helping people lose weight, build long-term healthy habits and reduce/eliminate medication for lifestyle diseases (example - Type 2 Diabetes). We are looking for ideas to improve our sales processes so that we can get users to enrol at a higher conversion rate post our 1-week free trial. We need to identify triggers when users are most likely to pay and provide them with a seamless process for paying on-the-spot.

We are a nonprofit stool bank, expanding safe access to fecal transplants and catalyzing research on the human microbiome.

Moons manufactures and sells orthodontic clear aligners in LATAM. Our focus is on providing excellent patient service whilst keeping prices accessible - we can do this because we make the aligners ourselves in our dental laboratory and sell the aligners exclusively in our own clinics

Joon is an integrated pediatric digital health platform for kids, starting with behavior disorders like ADHD, autism, anxiety, and depression. In Joon, kids access a game-based digital therapeutic where they level up when they do real-life behaviors that are managed by parents and clinicians. Over the next 10 years, we plan on being the first-line vertically integrated digital treatment for pediatric behavior disorders, leveraging the first of its kind technology to drive behavior change.

ParcelBio is developing a programmable technology to safely and specifically deliver mRNA to diverse cell types in the body. Our proprietary (nanoparticle-free) technology, which we call ‘STAmP’, stabilizes the mRNA and utilizes an interchangeable, lock-and-key-like targeting mechanism which enables fully customizable mRNA medicines.

At CellChorus, we apply artificial intelligence to evaluate thousands of microscopy videos in parallel to evaluate how immune cells move, interact and perform over time. This allows our customers to discover, develop, manufacture and deliver cell therapies, antibodies, vaccines and other novel therapies faster, at lower expense, and with higher rates of success. Our customers include top-25 biopharma companies and seed-stage biotechs that are developing cell therapies, antibody therapeutics and vaccines (including one of the few companies with an approved CAR T cell therapy). Hear from the team at https://www.youtube.com/watch?v=IE9x_tm0XnI

Junction Bioscience is building an autonomous AI scientist to navigate the discovery of transformative medicines. Our scientific hypothesis engine iterates upon breakthrough chemistry from the laboratory to achieve clarity and control over the molecular basis of disease. We focus on the intersection of neuroinflammation and immunology where uncommon molecular insights position us to develop best-in-class therapies for millions of patients in need.

Arini is the AI receptionist for dentists that answers phone calls, and schedules appointments. Most dental appointments are scheduled over the phone by overworked receptionists who put patients on hold and miss a third of incoming calls. This costs clinics a 15% loss in revenue. Private equity investment fueled large dental groups to acquire thousands of clinics in the past few years. We are selling to these groups, since their clinics have a standardized tech stack. They’re also growing really fast - in just two years they will make up 40% of the US dental market. Dental is just the beginning.

Velorum Therapeutics is developing a new class of cancer drugs that starve tumors by hijacking cancer metabolism.

NearWave makes a handheld imaging device that helps physicians select the right therapy for their breast cancer patients. This prevents patients from suffering through months of side effects caused by unsuccessful treatments.

At Pirouette, we have developed a low-profile, disk-shaped, rugged injection device with a patient-centric focus on affordability, portability, and usability. The patented device, based on extensive patient input, is designed to make administering an injection as easy as pushing a button. This allows individuals with limited or no training to easily and intuitively perform an injection on themselves or others.

Arpeggio Bio is a pioneering pharmaceutical company that develops drugs targeting transcription factors using AI and high-throughput RNA-sequencing. With $20M in venture funding, we've targeted "undruggable" proteins like NRF2, TEAD, and GPX4 where our lead program is rapidly progressing towards a DC for the treatment of IO-resistant melanoma. With partnerships with J&J and FORMA, we've validated our platform in rare disease and inflammation with a significant Phase I success.

Founded in 2022 and based in San Diego, California, Cisterna Biologics is a technology company. It aims to solve some of the challenges currently facing the biotech industry to develop mRNA-based therapeutics – quality, quantity, longevity and cost of mRNA. As mRNA technology matures, it becomes imperative that these issues are solved so we can fully explore mRNA's endless possibilities as a therapeutic. Cisterna uses proprietary technologies to either remove a contaminant at its source or replace the source itself. For example, to remove double-stranded RNA (dsRNA), we use ribozymes - molecular scissors - to precisely cut the mRNA at its 3’ end. This assures not only 3’ homogeneity, but also eliminates dsRNA, which are primarily produced due to self-templated additions at the 3’ end. Utilizing a PCR-like system to amplify the DNA template in large quantities eliminates the requirement for plasmid enrichment in bacteria, the prime source of endotoxin contamination. These are just a few examples of Cisterna’s powerful technologies being used to achieve our goal of 10x higher quality mRNA for therapeutic application.

Developing the next generation of psychedelic therapeutics for mental health indications. We design novel altered states of consciousness using machine learning, human experiential data, and molecular pharmacology.

Catena’s technology lets us attach any two proteins together using an enzyme and the native amino acids tyrosine and cysteine within target proteins. It is a true platform technology because it enables the joining of any two soluble proteins together with minimal engineering and without restrictions due to protein size or complexity. Our work has already been used to modify cancer specific antibodies, CRISPR proteins and even cell surfaces. Our ability to produce modular protein therapeutics in a fraction of the time allows for true library creation across the therapeutics spectrum from oncology, vaccines, inflammatory disease and beyond.

Neodocs lets you perform instant lab tests on your smartphone. Our users are health optimizers and athletes who want to improve key nutritional markers for better performance. You simply collect your sample, take a picture, and results are instantly generated. We are the perfect team to build this. Anurag is a 3-time medical entrepreneur who’s built medical devices, Pratik has worked on AI/ML models for leading US banks, and Nikunj comes from a consulting background at Bain & Co. We’re building your personal lab on your phone.

Brave Care is a group of kid-only primary & urgent care clinics that create a comfortable environment for little ones and reduce the stress and cost of emergency medicine for parents. We are 1/10th the cost of an ER trip and most often a visit can be completed in 1/4th the time. Common treatments: Pinkeye / Allergies / Tummy Bugs / Stitches / Broken Bones / Head Bumps / Sore Throats / Coughs / Fevers. Our digital services leverage our in-clinic medical professionals to reach across the country.

Clara is Deel/Rippling for in-home senior care. We provide an all-in-one payroll, tax, and insurance platform for families to directly employ caregivers, and a marketplace for them to discover and match with their ideal caregiver from our network of hundreds of qualified local care providers. Clara was founded by two former Uber colleagues who have experienced the challenges of managing care for a loved one personally, and are inspired by the opportunity to apply their tech backgrounds to solving the most widespread and impactful issues in the >$120B in-home care industry. Clara's marketplace is currently live in the SF Bay Area, delivering hundreds of hours of care to local families. Our consumer-facing senior-care payroll and tax management solution is live nationwide.

The Human Diagnosis Project (also referred to as “Human Dx” or “the Project”) is a worldwide effort to build an open medical intelligence system that maps the steps to help any patient. By combining collective intelligence with machine learning, Human Dx intends to enable more accurate, affordable, and accessible care for all

Redcliffe Labs (a unit of Redcliffe Lifetech Inc) provides diagnostics with a comprehensive portfolio approach both with routine and specialised test menus with advanced testing labs all over India. Its digital first approach with on-demand 1-hour home collection and same day report is disrupting the way diagnostics is delivered today and thus is the fastest growing in India. Redcliffe Labs is providing 3500+ tests across its wide network of labs and collection centres. The company has served about millions of Indians and is processing more than 250K+ test parameters daily. The test portfolio is very wide including routine pathology tests, advanced genetic screening, research-based DNA tests in reproductive health, cancer and wellness/fitness. The easy to interpret smart reports provide key health check-points, which can help in diagnosing and treating both chronic and acute diseases on time. Redcliffe Labs has pioneered Drone technology adoption in the diagnostic sector by opening up the first commercial corridor from Uttarkashi to Dehradun. The company currently has 30+ labs and 700+ authorised collection centres in more than 120 cities across India. Redcliffe's vision is to provide world-class diagnostic services to people across the Indian sub-continent in an affordable manner.

We make it easy for anyone in India to access healthcare over Zoom, Meet, or WhatsApp. We provide care in 11 local languages. For every appointment, we provide a concierge who manages all logistics for the patient & handles the back-office work for doctors. With this, we have cracked the code to make telehealth work in India.

Intellect is a modern-day mental health company on a mission to make mental healthcare & wellbeing support accessible for everyone in Asia. Today, Intellect is the largest and fastest growing mental health tech company in Asia, serving over 2.5 million members and leading organisations globally through our mental health platform. Intellect was also selected as one of Google’s Best Apps of 2020. Intellect is backed by leading investors including Insignia Ventures Partners, Y Combinator, and an extensive list of family offices, big tech executives & renowned angel investors.

Finding new cures requires seeing what and where the abnormal molecules are in a diseased tissue, but current tools see less than 1% of those molecules. Biocartesian combines microscopy and new chemistries to see 50X more, offering unprecedented insights into disease biology and new therapies.

PNOĒ enables health professionals to provide science-backed bio-optimization through breath analysis. For 100+ years, breath analysis (AKA metabolic testing, VO2max) has been the gold standard in anti-aging quantification, nutrition prescription, and evaluation of most critical systems, including the heart, lungs, cells, and nervous system. Until recently, it was only available in sophisticated clinics and regarded as the most valuable but underutilized assessment in medicine. PNOĒ changed that through the first easy-to-use clinical-grade breath analysis device, proprietary software package, and dedicated metabolic expert support. Through a non-invasive 10 min breath test, PNOĒ analyzes the human breath and prescribes a personalized nutrition, exercise, breathwork, and bio-optimization (i.e., red light therapy, hyperbaric chamber, IV therapy, etc.) program based on one’s biological limitations. 3,000+ health professionals trust PNOĒ because it personalizes the clients’ journey through their clinics, builds retention by quantifying progress, and enables the upsell of personalized nutrition and breathwork. All this without any effort, time commitment, or upfront cost. PNOĒ has been independently validated by Georgetown University, VA in Maryland, and Rutgers University and is trusted by leading institutions including Cenegenics, Dais Cove, MIT, UCLA, Pan Pacific, CLMBR, UCS, OURA, TONAL, Spartan Racing, and Paris Saint Germain.

Penciled (W24) helps physical therapists fill 10X more canceled appointments. The core of our product is an AI agent named Nicole. Nicole helps patients join the waitlist, maintains live availabilities, and texts and calls waitlist patients to fill canceled appointments. When fully deployed, Nicole fills 79% of cancellations detected and takes an average of 3 minutes to fill an appointment. Therapists using Nicole see a 194% increase in cancellations filled.

MetricWire’s mobile platform allows decision makers, researchers, and stakeholders to harness unparalleled insights solutions, analytical tools, and deeper audience connections. Our innovation has lead to real-time digital interventions, enriched research, and evidence-based decisions. Capture more powerful data and make better decisions

Brown Foods is a Stanford, Rice University and IIT Delhi alumni venture building the next-generation of food products. They are creating UnReal Milk- lab based, clean milk - extremely sustainable 'real milk' but made without any cows. Unlike any other option in the USD 22 billion dairy alternatives market today, it will be exactly similar to cow’s milk in terms of nutritional profile, taste, texture and could also be processed into butter, cheese and ice creams. They envision to disrupt the USD 700 billion conventional dairy market by giving the world its 1st 'cow free' real milk option, reducing the carbon footprint of milk by over 90% while being completely cruelty-free.

Biotechs use proteins found in nature, such as enzymes in bacteria or peptides in lizards, in a wide range of applications from chemical manufacturing to therapeutics. However, these naturally occurring proteins aren't optimized for industry. At AminoAnalytica, we specialize in AI-powered protein optimization. Using our proprietary computational tools, we can improve the properties of a target protein sequence, from the stability of therapeutic peptides to the activity of industrial enzymes. When we optimize a protein, it’s not just a theoretical suggestion—we work with labs to ensure that it’s functional, stable, and ready to change the world.

Have you ever wondered why it's so hard for physicians to communicate quickly and why the leading cause of preventable death is still a delay in communication? Our team has built the solution for this. Medigram is a team of tier 1 health system CxO IT executives, technologists, SaaS exec, physicians, engineers, and data experts. We have developed a breakthrough service for the medical industry to save lives and for hospitals to make millions per year. Medigram instantly flags insights from clinician chats for immediate insight into hospital operations and patient care. This reduces critical response times by 50%. We've designed this system to provide instant, reliable messaging (including images and audio files) across very complicated network environments in hospitals. Medigram is secure, designed for HIPAA, and a full stack system which includes database back end, middleware, logic, and client apps for iOS, Android, desktop, and the web. Our solution to this is Mobile Intelligence For Healthcare by providing a secure, intelligent workflow management platform for the patient care ecosystem and medical professionals. Within the healthcare environment, you have physicians, the patient care team, EMR, workflow, data, and administration which needs to be tied together with intelligence through Medigram.

Delivery of TERT mRNA extends telomeres sufficiently in a few days to reverse over a decade of telomere shortening during normal aging. We are advancing TERT mRNA-based therapies to the clinic.

mdhub is building AI assistants for mental health clinics to efficiently run their operations. Instead of seeing patients, mental health clinicians spend 50% of their time on other tasks, delaying access to mental health care. We aim to help mental health clinicians become 10x more efficient with mdhub by automating everything that occurs before, during, and after they see patients.

Our compounds disrupt the metabolic and inflammatory triggers in both cancer and quasi-cancerous cells in the tumor microenvironment. By impacting multiple cell types, we are enabling effective, lasting cancer treatments.

We have built a platform that enables drug discovery and development for previously undruggable genome regulators ("the regulome"). We accomplish this by moving drug discovery out of artificial systems where regulome proteins fail to function properly, and back into live human cells. Our technology combines innovations in automated cell processing, next-gen proteomics, and advanced data analytics to measure a drug's effect on the entire regulome in one experiment.

Our mission is to improve quality of life for millions of people by providing easy, immediate access to the world’s best sleep care. Sleep Reset is a digital, personalized sleep clinic, available in a convenient mobile app for iOS and Android. Our program was designed in partnership with leading sleep experts from top sleep clinics and universities. The program improves sleep and reduces sleep anxiety with the most effective methods from sleep clinics, including strategies based on Cognitive Behavioral Therapy for Insomnia (CBT-i) which are proven to be more effective than sleeping pills. Throughout our program, each member is paired with a dedicated sleep coach who personalizes their program. It’s a life-long, sustainable solution to sleep better in weeks, with no pills or melatonin needed – which means no grogginess, side effects, or dependency. Sleep Reset has been covered in Forbes, TechCrunch, and INSIDER. The company was founded by Yunha Kim, a serial entrepreneur recognized by Forbes as 30 Under 30 and is backed by top Silicon Valley investors including YCombinator, Foundation Capital, New Enterprise Associates, Stanford University and 20+ founders/executives of leading companies.

Oto’s digital programs are the best way to manage tinnitus, and at a fraction of the cost of in person treatment. Tinnitus or ringing in the ears affects 1 in 8 people, and before Oto effective therapy was only available via expensive meetings with a specialist.

LEAH Labs is building living therapies for pets first, and their people next. We're first focused on CAR-T cell therapy for dogs with B cell lymphoma, the naturally occurring clinical analog of human non-Hodgkin's lymphoma. CAR-T cells are curative in humans, and our early results are showing the same - we're inducing remissions in pets with late stage lymphomas. Our virus-free gene editing platform allows us to engineer a dose of CAR-T cell therapy for ~$500, and brings the promise of a curative outcome. Given our safety and efficacy data to date, we believe this product could be used by general practice veterinarians, meaning we have thousands of customers all across the USA who typically treat with palliative care or refer cancer patients to specialty oncologists. Our CAR-T cell platform is regulated by the USDA, not the FDA, affording us a cost effective "full stack" to iterate and innovate on CAR-T cell therapy from a hypothesis through clinical validation.